Amyotrophic Lateral Sclerosis Clinical Trials in Miami, Florida

6 studies are recruiting for amyotrophic lateral sclerosis in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS

   PIONEER-ALS is a Phase 1/2, multicenter, open-label, ascending dose, uncontrolled, first-in-human study that will evaluate the safety, tolerability and effects on clinical and biomarker endpoints of intracisternal administration of Vtx-002 in participants with Amyotrophic Lateral Sclerosis (ALS). T…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   University of Miami School of Science, Miami, Florida

   Locations

   11 in total

   Run by

   Vector Y Therapeutics

   See if you can join NCT07287397 on ClinicalTrials.gov

2. Clinical Procedures to Support Research in ALS

   The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Miami, Miami, Florida

   Locations

   11 in total

   Run by

   University of Miami

   See if you can join NCT03489278 on ClinicalTrials.gov

3. Clinical Research in ALS Study

   CRiALS is an umbrella protocol through which people are recruited to participate in a range of research studies being conducted by the ALS Research Collaboration (ARC).

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Miami, Miami, Florida

   Run by

   University of Miami

   See if you can join NCT00136500 on ClinicalTrials.gov

4. The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study

   Pre-fALS is a prospective natural history and biomarker study of people not yet affected with ALS, but who are at genetic risk for developing ALS. The investigators aim to recruit unaffected (healthy) people from familial ALS (fALS) pedigrees in which a known genetic mutation associated with ALS ha…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Miami, Miami, Florida

   Run by

   University of Miami

   See if you can join NCT00317616 on ClinicalTrials.gov

5. Intermuscular Coherence as a Biomarker for ALS

   The specific aims of this study are to: 1. Determine if a painless and quick measurement of muscle activity using surface electrodes can help with the diagnosis of ALS. Specifically, we ask if a measure of intermuscular coherence (IMC-βγ), when added to current diagnostic criteria (Awaji criteria),…

   Stage

   Not phased

   Ages

   20 to 90

   Site

   University of Miami Miller School of Medicine, Miami, Florida

   Locations

   4 in total

   Run by

   University of Chicago

   See if you can join NCT05104710 on ClinicalTrials.gov

6. Precise Robotically IMplanted Brain-Computer InterfacE

   The PRIME Study is a first-in-human early feasibility study to evaluate the initial clinical safety and device functionality of the Neuralink N1 Implant and R1 Robot device designs in participants with tetraparesis or tetraplegia. The N1 Implant is a skull-mounted, wireless, rechargeable implant co…

   Stage

   Not phased

   Ages

   22 to 75

   Site

   University of Miami, Miami, Florida

   Locations

   2 in total

   Run by

   Neuralink Corp

   See if you can join NCT06429735 on ClinicalTrials.gov